PAA 2.63% 19.5¢ pharmaust limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1288

  1. 635 Posts.
    lightbulb Created with Sketch. 114
    I agree with you there ldrink2that.

    I was thinking that high value expectation vs maybe what the board thought about its value, and wanting to do didn’t sit well somewhere…
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.